Chemify and Prepaire™ Labs announced to expand their partnership with an additional program to tackle the ongoing Opioid crisis and develop a novel class of digitally discovered non-addictive Opioids as pain modulators, as well as drugs tackling Opioid addiction directly by combining Chemify's breakthrough programmable chemistry platform with Prepaire’s integrated novel...
Certis Oncology Solutions, a precision oncology and translational science company focused on combining AI-directed drug development with advanced functional testing, announced that it raised $10 million in a Series C funding round, bringing total raised to $42 million. The company also named John R. Tozzi Chairman of its Board of...
DermaSensor Inc. announces FDA clearance for its real-time, non-invasive skin cancer evaluation system. For the first time, the 300,000 primary care physicians in the U.S. can now be equipped to provide quantitative, point-of-care testing for all types of skin cancer. Better identifying skin cancer in a primary care setting is...
Rad AI, a leading AI start-up for radiology reporting, announced a partnership with Google to use its cloud and AI innovations to help save radiologists' time, reduce burnout, and to ultimately improve the quality of patient care. Specifically, this alliance will involve Rad AI using Google Cloud's platform and...
Life Sciences Ontario is pleased to announce the recipients of its 2024 LSO Awards, recognizing outstanding individuals and companies contributing to the success of Ontario’s life sciences sector. The awards will be presented during LSO’s Celebration of Success Awards Presentation on Wednesday, May 15th, 2024 at the Liberty Grand,...
Debiopharm, an independent biopharmaceutical company headquartered in Switzerland, and ThinkingNodeLife.ai (TNL), a trailblazer in AI Digital Cells Lab in USA, are pleased to announce a collaborative partnership aimed at advancing the development of a cutting-edge cancer drug. This strategic alliance leverages the unique capabilities of TNL’s AI Digital Cells...
ConcertAI and Caris Life Sciences (Caris) announced a multi-year partnership to support AbbVie's precision medicine-driven research and development efforts, and clinical trial optimization in oncology.
The agreement will allow AbbVie to leverage Caris' expansive real-world, multi-modal database in oncology and ConcertAI's collection of research-grade clinical data across a wide range...
Paige, a global leader in end-to-end digital pathology solutions and clinical AI applications, announced the release of a groundbreaking product developed from Paige’s Pathology Foundation Model, Virchow. Built using one of the largest libraries of digitized images, utilizing unique computational resources provided by Microsoft Research, Paige has developed the first...
insitro, a machine learning-powered drug discovery and development company, announced the appointment of S. Michael Rothenberg, M.D., Ph.D., as chief medical officer. In this new role, which begins in February, Dr. Rothenberg will lead all aspects of clinical development, including strategy on clinical trial design; oversee medical affairs, pharmacovigilance...
Deepcell, a pioneer in artificial intelligence (AI)-powered single cell analysis to fuel deep biological discoveries, announced a research collaboration with NVIDIA to accelerate the development and adoption of advanced computer vision solutions in life sciences. Deepcell, which already uses the NVIDIA A4000 and NVIDIA AI technology, will incorporate NVIDIA...
